baber/WOPTO huggingface dataset:
Patent DE-69308744-T2 (DE)
Inventor: BATHELET PIERRE
IPC: B01D63/06
Filed: 1993-10-15
Granted: 1997-06-26
Abstract: Seal 7, 7a for a filtration module (1), comprising a bundle of membranes (3), (3a), (3b) which are arranged inside a casing (2) and held at both of their ends by a perforated plate (P1), (P2), each end of the membrane passing through aligned perforations of the plates (P1), (P2), of the seal (7), (7a) and backing plates (4), the said seal (7), (7a) being characterised in that it consists in its thickness of 3 superposed regions, the 2 outer regions (24), (25) having a Shore A hardness of at least 65 and the middle region (26) having a Shore A hardness lower than 55.
Patent DE-69317393-T2 (DE)
Inventor: KEYES DENIS E
IPC: A61F5/445
Filed: 1993-12-20
Granted: 1998-07-30
Abstract: An ostomy pouch formed of a flexible plastic material has a waste inlet opening 28 and a gas outlet opening 38 proximate the waste inlet opening. The gas outlet opening is of a configuration and size that resists entry of outside water into the pouch through the gas outlet opening. A deodorizing filter 44 aligned with the gas outlet opening 38 is bonded at a peripheral zone 50 surrounding the gas outlet opening, leaving an unbonded area 52 that communicates with the gas outlet opening 38. A free face of the filter is gas impermeable. Gases within the pouch pass through an exposed, gas permeable peripheral edge of the filter toward the center and exit into the unbonded section for evacuation through the gas outlet opening. <IMAGE>
Patent DE-69322580-T2 (DE)
Inventor: SHIMAKURA MASAMI
IPC: G09G5/18
Filed: 1993-09-03
Granted: 1999-06-17
Abstract: A display control apparatus includes a display data memory for storing display data, a display controller capable of sequentially reading out the display data stored in the memory and transferring the readout display data to the display device at a predetermined period and capable of performing a partial rewrite operation of the display data stored in the memory, a rewrite detector for detecting an address for accessing the display data memory to cause the display controller to perform the partial rewrite operation, and a transfer permitting unit for reading the address detected by the rewrite detector and permitting transfer of only the display data of the read address to the display controller. <IMAGE>
Patent DE-69330830-T2 (DE)
Inventor: MORENO MARIO
IPC: A61M5/32
Filed: 1993-04-27
Granted: 2002-06-06
Abstract: A needle suitable for piercing a septum of a vacuum sealed container and through which a measured fluid sample from the container may be withdrawn. The needle is capable of withdrawing fluid from small sample volumes, such that the dead volume remaining in the sealed container is reduced. The needle has an elongated body having a longitudinal axis, an unobstructed bore therethrough along the longitudinal axis, a free end, and an end region adjacent said free end which has a slight conical taper toward said free end at a predetermined angle relative to the longitudinal axis. The free end includes an oblique cut through the conically tapered end region at an angle relative to the longitudinal axis being substantially larger than the predetermined angle of the taper so as to produce an elliptical opening at the free end. The elliptical opening lies along a plane diagonal to the longitudinal axis. This produces a toe or tip that is reduced in height allowing for a decrease in dead volume.
Patent DE-69333453-T2 (DE)
Inventor: KENNEDY PAUL E
IPC: A61K9/19
Filed: 1993-07-30
Granted: 2005-01-27
Abstract: The present invention relates to a sterile, stable vacuum dried crystalline amifostine composition and, optionally, pharmaceutically acceptable excipient(s). Typically, the crystalline compositions of the present invention exhibit enhanced stability at temperatures ranging from about 4 DEG  C. to about ambient temperature for a period of at least 2 years relative to existing solid vacuum dried amorphous amifostine preparations. The reconstituted compositions of the present invention are suitable for administration to humans as a radio- or chemoprotecting agent.
Patent DE-69407269-T2 (DE)
Inventor: GRASMEDER JOHN RUSSELL
IPC: C08L63/00
Filed: 1994-01-26
Granted: 1998-04-02
Abstract: PCT No. PCT/GB94/00148 Sec. 371 Date Jul. 19, 1995 Sec. 102(e) Date Jul. 19, 1995 PCT Filed Jan. 29, 1994 PCT Pub. No. WO94/18267 PCT Pub. Date Aug. 18, 1994Filled polymer compositions having improved scratch resistance comprise as a major component a polymer resin blend itself comprising 70 to 95% polypropylene homopolymer, and 5 to 30% low density polyethylene, particularly lldpe or vldpe; and 5 to 30% plate like inorganic filler. Optional components include high rubber ethylene-propylene copolymers, fatty acid amides, polyorganosiloxanes and epoxy resins as well as pigments, antioxidants etc. The compositions are formed by mixing the plate like filler and the epoxy resin prior to mixing with another component of the composition which is significantly absorbed by the plate like filler, and subsequently mixing the components of the composition in the melt phase, particularly in a twin screw extruded, and extruding the composition. The compositions find use in vehicle interior trim components, which particularly include polyorganosiloxane, and domestic appliance components, particularly housings, which particularly include high rubber ethylene-propylene copolymer.
Patent DE-69412681-T2 (DE)
Inventor: GARDNER TERRY
IPC: A01G27/04
Filed: 1994-04-11
Granted: 1999-05-06
Abstract: A container (1) made for instance of ceramic, terracotta, or plastic material, is capable of supporting conventional vessels (4) by means of a plate (3) which is provided with openings. The vessels have a top peripheral border (5) which protrudes with respect to the peripheral border of the container so that the vessels are raised from the bottom of the container. Water is placed at the bottom of the container, some strips of felt (9) or similar absorbing material is inserted into the vessel and reaches the bottom of the container so that water is transferred to the soil by capillary action and also by evaporation. The containers consist of three compartments; the upper compartment (7) containing the soil, the lower compartment (6) containing the water, and an intermediate compartment (24) forming an air chamber. The walls (the container (1), the plate (3), and the vessel(s) [4]) containing the air chamber (24) act as an evaporation barrier. As water evaporates from the reservoir (6) it condenses along the walls containing the air chamber (24). Water is thereby reclaimed by the reservoir or is absorbed by the soil in the upper chamber (7). <IMAGE>
Patent DE-69413333-T2 (DE)
Inventor: CORDI ALEX
IPC: A61P25/20
Filed: 1994-07-06
Granted: 1999-05-12
Abstract: Compounds of formula (I): <IMAGE>  in which:   - X represents -CH2-, -(CH2)2-, -CH=CH-, -O-CH2-, -S-CH2-, -SO-CH2- or -SO2-CH2-,   - Y represents an oxygen or sulphur atom or a group -NR5-, - R represents a halogen atom, a linear or branched (C1-C6)alkyl group (substituted or unsubstituted), a hydroxyl group or a linear or branched (C1-C6)alkoxy group, - R2 represents a hydrogen or halogen atom, a linear or branched (C1-C6)alkyl group (substituted or unsubstituted), a hydroxyl group, a linear or branched (C1-C6)alkoxy group or a linear or branched (C1-C6)alkylthio group, - R3 represents a hydrogen or halogen atom, a linear or branched (C1-C6)alkyl group (substituted or unsubstituted), a hydroxyl group, a linear or branched (C1-C6)alkoxy group or a linear or branched (C1-C6)alkylthio group, - R4 represents a hydrogen atom or an amino group (substituted or unsubstituted), - R5 represents a hydrogen atom or a linear or branched (C1-C6)alkyl group, or else -R1 and R2 form, together with the carbon atoms which carry them, a benzene ring, provided that, in this case, X represents -CH2- or -(CH2)2-, their isomers and their addition salts with a pharmaceutically acceptable acid. Medicaments.
Patent DE-69413431-T2 (DE)
Inventor: TRAINI CARLO
IPC: C25B9/19
Filed: 1994-02-11
Granted: 1999-06-17
Abstract: A chlor-alkali diaphragm electrolysis cells comprising pairs of interleaved anodes (B) and cathodes (C), said cathodes having surfaces provided with openings and coated by porous, corrosion resistant diaphragms, said cell further comprising feed brine inlets and outlets for the removal of the chlorine, hydrogen and caustic, said anodes being of the expandable type provided with internal extenders (F) and electrode surfaces with openings for the release of the produced gaseous chlorine, characterized in that the anodes (B) have at least one pressing means (O, Q) made of corrosion resistant material having elastic properties to maintain under constant and homogeneously distributed pressure the electrode surfaces of the anodes against the diaphragms. The anodes are preferably equipped with thin expanded meshes (M) fixed to each of the electrode surfaces facing the diaphragm and with hydrodynamic means (P) suitable for increasing the internal circulation. <IMAGE>
Patent DE-69415535-T2 (DE)
Inventor: ZORGNIOTTI ADRIAN W
IPC: A61K31/44
Filed: 1994-08-10
Granted: 1999-06-17
Abstract: The invention is directed to improved methods for modulating the human sexual response by administering a vasodilator to the circulation by a route of administration that avoids the "first-pass" effect.
Patent DE-69416160-T2 (DE)
Inventor: NOVOTNY PAUL
IPC: C22C38/46
Filed: 1994-10-24
Granted: 1999-08-12
Abstract: A martensitic steel alloy has a unique combination of hardness and corrosion resistance. Broadly stated, the alloy contains, in weight percent, about -C 1.40-1.75 -Mn 0.30-1.0 -Si 0.80 max. -P 0.020 max. -S 0.015 max. -Cr 13.5-18.0 -Ni 0.15-0.65 -Mo 0.40-1.50 -V 1.0 max. -N 0.02-0.08 -  and the balance essentially iron. The alloy is balanced within the stated weight percent ranges such that the ratio %Cr:%C is about 10.0-11.0 and the sum %Ni+%Mn is at least about 0.75. The alloy can be hardened to at least about 60 HRC from a wide range of solution treating temperatures and provides corrosion resistance that is similar to Type 440C alloy.
Patent DE-69419782-T2 (DE)
Inventor: SABHARWAL HEMANT
IPC: A23K1/16
Filed: 1994-08-16
Granted: 1999-12-23
Abstract: The present invention relates to the use of alpha-lactalbumin in the preparation of preparations to be used in therapeutic or prophylactic treatment and/or for diagnostic use for infections, preferably of the respiratory tract, caused by bacteria, in particular S. pneumoniae and/or H. influenzae. The present invention further relates to essentially pure protein complexes comprising alpha-lactalbumin and the use of these protein complexes for therapeutically or prophylactically treating a bacterial infection, especially infections of the respiratory tract caused by S. pneumoniae and/or H. influenzae.
Patent DE-69423851-T2 (DE)
Inventor: OETIKER HANS
IPC: F16L33/02
Filed: 1994-10-27
Granted: 2000-12-14
Abstract: The structure, comprises clamping band device, device for tightening the clamp structure about an object to be fastened thereby, and further device for holding the clamping band device in its tightened condition in such a manner that it provides internal clamping surfaces devoid of any discontinuity, step or offset over its entire circumference to assure a completely satisfactory fluid tight connection. The further device includes a tongue-like extension at one end of the clamping band having outwardly extending hook, and a slot-like opening extending in the circumferential direction within the area of the opposite fork-like end portion of the clamping band device.
Patent DE-69425378-T2 (DE)
Inventor: MOTSON RUSSELL
IPC: C09K23/34
Filed: 1994-08-19
Granted: 2000-11-30
Abstract: PCT No. PCT/GB94/01815 Sec. 371 Date Feb. 22, 1996 Sec. 102(e) Date Feb. 22, 1996 PCT Filed Aug. 19, 1994 PCT Pub. No. WO95/06096 PCT Pub. Date Mar. 2, 1995Surfactants of the general formula (I): Y.A1.OC.(HR)C.C(HR1).CO.A.(CmH2mO)n.R2 or (II): Y.A1.OC.(HR)C.C(HR1).CO.A.(CmH2mO)n.CpH2p.A.CO.(HR1)C.C(HR)CO.A1.Y; where R, R1, R2, A, A1, n, m, Y and p have defined meanings are effective in single phase aqueous surfactant compositions with high electrolyte loading, especially of or including alkali, particularly for hard surface cleaning applications. These surfactants do not need hydrotropes to give stable single phase compositions even with high electrolyte loadings and are resistant to hydrolytic degradation e.g. by strong alkali in such compositions.
Patent DE-69432104-T2 (DE)
Inventor: WHITE NEAL EDWIN
IPC: A23G9/16
Filed: 1994-09-27
Granted: 2003-10-09
Abstract: A system and method for making a frozen confection having a plurality of differently flavored or colored sections are provided. After partially freezing in a mold the ingredients for a first flavor or color to form a frozen outer layer and a liquid inner core, the liquid inner core is vacuumed from the mold. A carving tool, such as a laser, then is inserted into the area of the mold previously occupied by the liquid inner core. The carving tool removes a portion of the frozen outer layer in accordance with a predetermined pattern. The ingredients for a second flavor or color then are inserted into the mold to fill the inner core and the areas of the outer layer removed with the carving tool. The mold then is subjected to freezing to form the final product.
Patent DE-69432424-T2 (DE)
Inventor: GORDON JULIAN
IPC: C12Q1/686
Filed: 1994-09-28
Granted: 2004-03-18
Abstract: Methods, devices, apparatus and kits for amplifying and detecting ligands such as nucleic acids are provided. The apparatus may be a two-tier thermal cycling device that can operate in conjunction with a sealed reaction/detection unit. A sample is loaded into a reaction chamber of the device which is then mated with a detection chamber to form the reaction/detection unit. The reaction mixture may be transferred to the detection chamber by a heating element and expansion of a fluid. The target ligand becomes immobilized in a predetermined array on a support in the detection chamber. A video imaging system associated with the apparatus detects and analyzes the immobilized ligand. Images are captured, digitized and subjected to statistical analysis to improve the accuracy of the imaging method.
Patent DE-69433024-T2 (DE)
Inventor: OGLE FRANK L
IPC: B26B19/06
Filed: 1994-06-02
Granted: 2004-06-09
Abstract: A hair clipper body (10) has a support tongue (34) pivoted on an inclined front end (9). A cutter head assembly (12) engages with the clipper body using a tongue receiving socket (42) having a strap (40) on the bottom blade (14). Projections (50,52) are received in slots (44,46) when the support tongue is inserted and the head is attached to the body. The cutting head can be engaged with the body but engagement is prevented with different heads or bodies.
Patent DE-69433091-T2 (DE)
Inventor: COLLER BARRY S
IPC: C12N15/09
Filed: 1994-11-07
Granted: 2004-06-03
Abstract: Platelet-specific, chimeric immunoglobulin and immunoglobulin fragments are described. The chimeric molecules are made up of a nonhuman antigen binding region and a human constant region. Preferred immunoglobulins are specific for glycoprotein IIb/IIIa receptor in its complexed form; they block ligand binding to the receptor and prevent platelet aggregation. The immunoglobulins can be used to reduce or prevent occlusion, reocclusion (e.g, abrupt closure), stenosis and/or restenosis. In addition, the immunoglobulins are useful in anti-thrombotic therapy when administered alone or in conjunction with thrombolytic agents, as well as in thrombus imaging.
Patent DE-69434185-T2 (DE)
Inventor: IMRAN MIR A
IPC: A61B18/14
Filed: 1994-05-31
Granted: 2005-06-02
Abstract: A transurethral radio frequency apparatus for ablation of the prostate gland through the urethra formed by a wall, a probe consisting of a flexible elongate tubular member with proximal and distal extremities and sized so as to be adapted to be inserted into the urethra, and an ablation electrode carried by the distal extremity of the flexible elongate member. The flexible elongate tubular member is provided with first and second flow lumens for delivering a cooled fluid to the ablation electrode to cool the same. Means are connected to the probe to supply a coolant solution to the probe, to supply radio frequency energy to the electrode while it is being cooled, and to monitor the temperature of the ablation electrode so that the ablation electrode is maintained at a temperature below a predetermined temperature to spare the urethral wall from irreversible damage from the radio frequency energy delivered to the ablation electrode.
Patent DE-69435002-T2 (DE)
Inventor: ARSENAULT A LARRY
IPC: A61K47/42
Filed: 1994-07-19
Granted: 2008-03-20
Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
Patent DE-69502885-T2 (DE)
Inventor: MCCUE DAVID S
IPC: A47F10/04
Filed: 1995-07-17
Granted: 1999-02-11
Abstract: A shopping cart station (10) has free-standing first and second hollow wall members (1,3) at least partially filled with a ballast material. A connecting element (5) couples the first and second hollow wall members (1,3) together. The cart station (10) can be easily moved and secured by emptying the hollow wall elements (1,3) of the ballast material, repositioning the cart station (10), and refilling the wall members with ballast. <MATH>
Patent DE-69507778-T2 (DE)
Inventor: ALTENBURGER JEAN MICHEL
IPC: C07D333/20
Filed: 1995-11-21
Granted: 1999-09-16
Abstract: Cpds. of formula (I) are new. In (I), R4 i H, halo or NO2; R6 is H or 1-6C alkyl; R7 is Cl or OH; and Z is I (when R7 is Cl), phenyl (opt. substd. by one or more halo; 1-4C alkyl or alkoxy; CF3; formyl; CH2OR; CH2OCOR; CH2CONRR'; CHONCOR; COOR; NO2; NHR; NRR' or NHCOR), heterocycle such as pyridinyl, thienyl, furyl, thiazolyl and pyrimidyl (opt. substd. as above) or 5-8C cycloalkyl when R7 is Cl or OH (free or as an alkali metal or tert. amine salt); and R and R' are H or 1-7C alkyl.
Patent DE-69511163-T2 (DE)
Inventor: OGATA KAZUMI
IPC: C07D311/72
Filed: 1995-05-18
Granted: 1999-11-25
Abstract: This invention provides a tocopherol derivative of the following formula (I) or a pharmacologically acceptable salt thereof <CHEM> wherein R1 and R2 are the same or different and each represents hydrogen or methyl; R3 represents an  alpha -amino acid,  omega -amino acid, or peptide bonding via the N terminus thereof, except that in the case of cysteine or glutathione which has a thiol group, bonding via the thiol group. The tocopherol derivative of this invention is a compound which is water-soluble and can be expected to be of use as a cerebral function-improving drug and an anticataract drug. Moreover, this compound is of value as an UV-absorber, a skin care ingredient, or a stabilizer for other cosmetic ingredients.
Patent DE-69515038-T2 (DE)
Inventor: GLASEBROOK ANDREW LAWRENCE
IPC: A61K31/55
Filed: 1995-08-21
Granted: 2000-06-29
Abstract: A method of inhibiting viral replication comprising administering to a human in need thereof an effective amount of a compound having the formula    <IMAGE>  (I)  wherein R1 and R3 are independently hydrogen, -CH3,   <IMAGE>   wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Patent DE-69525291-T2 (DE)
Inventor: BLACK LARRY JOHN
IPC: A61K31/035
Filed: 1995-07-20
Granted: 2002-09-19
Abstract: The present invention provides a method for inhibiting bone loss comprising administering to a human in need thereof a first compound selected from 1) triarylethylenes; 2) 2,3-diaryl-2H-1-benzopyrans, 3) 1-aminoalkyl-2-phenylindoles; 4) 2-phenyl-3-aroylbenzothiophenes, 5) 1-substituted-2-aryl-dihydronaphthalenes; or 6) benzofurans, and a second compound being a bisphosphonate: or pharmaceutically acceptable salts and solvates thereof. Also encompassed by the invention are combination pharmaceutical formulations and salts.
Patent DE-69527646-T2 (DE)
Inventor: CALDWELL W
IPC: H03K17/96
Filed: 1995-10-25
Granted: 2003-02-20
Abstract: Each of a plurality of touch pads for detecting manual contact by a human user and capable of activating a control device comprises a dielectric substrate (10) of substantially uniform thickness. A first thin conductive electrode pad (16) is disposed on a first surface of the substrate in a closed, continuous geometric form having an area which affords substantial coverage by a human appendage. A second thin, conductive electrode (18) is also disposed on the first surface of the substrate (10) and surrounds, but is spaced from, the first conductive electrode (16) on peripheral edges having an adjacent touch pad. <IMAGE>
Patent DE-69528914-T2 (DE)
Inventor: PARKER KENNETH P
IPC: G01R31/28
Filed: 1995-02-17
Granted: 2003-07-31
Abstract: A method for generating improved detection and diagnostic test patterns and for improving the diagnostic resolution of interconnect testing of a circuit is based on the premise that short-circuits are most likely to result from solder bridges between closely adjacent pins. In a first embodiment, an optimal boundary-scan test pattern is generated. In a second embodiment, boundary-scan test diagnosis is enhanced. In a third embodiment, diagnosis of unpowered short-circuit testing is enhanced. <IMAGE>
Patent DE-69533516-T2 (DE)
Inventor: JAMES JR
IPC: C12N15/82
Filed: 1995-10-23
Granted: 2005-08-18
Abstract: The present invention provides polynucleotide sequences from FAE1 genes. FAE1 genes encode elongation enzymes which catalyze the conversion of C18 FAs to C20-C22 FAs. The polynucleotides of the invention are used to modify FAE1 gene expression and thereby modulate FA content in plant organs or parts, particularly seeds.
Patent DE-69533596-T2 (DE)
Inventor: GOCHENOUR DANIEL V
IPC: F16D13/71
Filed: 1995-06-12
Granted: 2005-10-06
Abstract: A friction device includes an adjustment mechanism for adjusting the device in response to wear on a friction surface within the device. The adjustment mechanism includes a first cam ring and a second cam ring adjacent the first cam ring. In one embodiment, the first cam ring is adapted for axial, but non-rotational movement with respect to a cover of the friction device, the cover being secured to a driving member for transmitting torque. The second cam ring is adapted for rotational movement with respect to the cover and the first cam ring. The first cam ring has a plurality of annular ramped surfaces on an axial face of the first cam ring. The second cam ring has a plurality of annular ramped surfaces on an axial face opposing the axial face of the first cam ring. The second cam ring is rotated with respect to the first cam ring such that the ramped surfaces cam against each other to increase the axial displacement of the first cam ring and the second cam ring, whereby the axial displacement is adapted to compensate for wear on a friction surface of a member of the friction device.
Patent DE-69609032-T2 (DE)
Inventor: BETREMIEUX ISABELLE
IPC: C08L71/00
Filed: 1996-04-23
Granted: 2001-02-15
Abstract: PCT No. PCT/FR96/00618 Sec. 371 Date Jun. 3, 1997 Sec. 102(e) Date Jun. 3, 1997 PCT Filed Apr. 23, 1996 PCT Pub. No. WO96/34048 PCT Pub. Date Oct. 31, 1996The present invention relates to a vulcanized mixture: (i) of at least one functionalized rubber and (ii) of at least one thermoplastic in an amount which is sufficient to increase the modulus at small elongations but such that the breaking stress is not reduced by more than 10%. The thermoplastic can be chosen from polyamides and copolymers containing polyamide blocks and polyether blocks.